EyePoint Pharmaceuticals, Inc. (EYPT) Financials
EYPT Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 329.2 million | 79.3 million |
| 2023-12-31 | 355.2 million | 88.9 million |
| 2023-09-30 | 160.0 million | 101.4 million |
| 2023-06-30 | 175.7 million | 118.4 million |
EYPT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | -32.4 million | 12.7 million |
| 2023-12-31 | -24.0 million | 3.6 million |
| 2023-09-30 | -16.9 million | 3.6 million |
| 2023-06-30 | 56.6 million | 1.8 million |
EYPT Net Income
No data available :(
EYPT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 299.3 million | - | 4.6 million |
| 2023-12-31 | 331.1 million | - | 4.9 million |
| 2023-09-30 | 136.0 million | - | 5.2 million |
| 2023-06-30 | 142.5 million | - | 5.5 million |
EYPT Shares Outstanding
EYPT Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 1.2 million | 30.1 million | 14.1 million | 6000 |
| 2023-12-31 | 883000 | 18.0 million | 11.2 million | 185000 |
| 2023-09-30 | 1.7 million | 17.4 million | 10.6 million | 479000 |
| 2023-06-30 | 396000 | 15.7 million | 9.1 million | 5.3 million |
EYPT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 11.7 million | 759000 |
| 2023-12-31 | 14.0 million | 998000 |
| 2023-09-30 | 15.2 million | 1.2 million |
| 2023-06-30 | 9.1 million | 1.8 million |
EYPT
Price: $10.71
52 week price:
Earnings Per Share: -1.81 USD
P/E Ratio: -11.14
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 166382
Market Capitalization: 674.0 million